{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:02:40Z","timestamp":1776196960717,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T00:00:00Z","timestamp":1281916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1546-0096-8-23","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T02:15:13Z","timestamp":1282011313000},"source":"Crossref","is-referenced-by-count":28,"title":["Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?"],"prefix":"10.1186","volume":"8","author":[{"given":"Randy Q","family":"Cron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Beukelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"397_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/nm939","volume":"9","author":"M Feldmann","year":"2003","unstructured":"Feldmann M, Maini RN: Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003, 9: 1245-1250. 10.1038\/nm939.","journal-title":"Nat Med"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000, 342: 763-769. 10.1056\/NEJM200003163421103.","journal-title":"N Engl J Med"},{"key":"397_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH: Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008, 58: 1496-1504. 10.1002\/art.23427.","journal-title":"Arthritis Rheum"},{"key":"397_CR4","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/art.27511","volume":"62","author":"P Diak","year":"2010","unstructured":"Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A: Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 2010, 62: 2517-2524. 10.1002\/art.27511.","journal-title":"Arthritis Rheum"},{"key":"397_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1546-0096-8-18","volume":"8","author":"P McCroskery","year":"2010","unstructured":"McCroskery P, Wallace CA, Lovell DJ, Stryker S, Chernyukhin N, Blosch C, Zack DJ: Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheumatol Online J. 2010, 8: 18-10.1186\/1546-0096-8-18.","journal-title":"Pediatr Rheumatol Online J"},{"key":"397_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/adc.86.1.47","volume":"86","author":"AG Cleary","year":"2002","unstructured":"Cleary AG, McDowell H, Sills JA: Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child. 2002, 86: 47-49. 10.1136\/adc.86.1.47.","journal-title":"Arch Dis Child"},{"key":"397_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/ard.2005.044784","volume":"65","author":"J Franklin","year":"2006","unstructured":"Franklin J, Lunt M, Bunn D, Symmons D, Silman A: Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis. Ann Rheum Dis. 2006, 65: 617-622. 10.1136\/ard.2005.044784.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl3","key":"397_CR8","first-page":"631","volume":"69","author":"M Harrison","year":"2010","unstructured":"Harrison M, Nordstom B, Gu Y, Mercaldi C, Aquino P, Mines D: Risk of malignancy in biologics-naive juvenile arthritis patients (abstract). Ann Rheum Dis. 2010, 69 (Suppl3): 631-","journal-title":"Ann Rheum Dis"},{"issue":"Suppl3","key":"397_CR9","first-page":"81","volume":"69","author":"JF Simard","year":"2010","unstructured":"Simard JF, Neovius M, Hagelberg S, Askling J: Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study (abstract). Ann Rheum Dis. 2010, 69 (Suppl3): 81-","journal-title":"Ann Rheum Dis"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3816\/CLM.2008.n.009","volume":"8","author":"R Kaiser","year":"2008","unstructured":"Kaiser R: Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature. Clin Lymphoma Myeloma. 2008, 8: 87-93. 10.3816\/CLM.2008.n.009.","journal-title":"Clin Lymphoma Myeloma"},{"key":"397_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/ard.2007.085852","volume":"68","author":"J Askling","year":"2009","unstructured":"Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Coster L, Jacobsson LT, Lindblad S, Lysholm J, Rantap\u00e4\u00e4-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N: Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis. 2009, 68: 648-653. 10.1136\/ard.2007.085852.","journal-title":"Ann Rheum Dis"},{"key":"397_CR12","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/art.22864","volume":"56","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K: Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum. 2007, 56: 2886-2895. 10.1002\/art.22864.","journal-title":"Arthritis Rheum"},{"key":"397_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/157488709789957664","volume":"4","author":"PL Lakatos","year":"2009","unstructured":"Lakatos PL: Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?. Rev Recent Clin Trials. 2009, 4: 152-158. 10.2174\/157488709789957664.","journal-title":"Rev Recent Clin Trials"},{"key":"397_CR14","doi-asserted-by":"crossref","unstructured":"Ochenrider MG, Patterson DJ, Aboulafia DM: Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review. Clin Lymphoma Myeloma Leuk. 10: 144-148. 10.3816\/CLML.2010.n.021.","DOI":"10.3816\/CLML.2010.n.021"},{"key":"397_CR15","doi-asserted-by":"crossref","unstructured":"Savage KJ: Prognosis and primary therapy in peripheral T-cell lymphomas. Hematology Am Soc Hematol Educ Program. 2008: 280-288.","DOI":"10.1182\/asheducation-2008.1.280"},{"key":"397_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/ncprheum0438","volume":"3","author":"WF Rigby","year":"2007","unstructured":"Rigby WF: Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?. Nat Clin Pract Rheumatol. 2007, 3: 227-233. 10.1038\/ncprheum0438.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"397_CR17","doi-asserted-by":"crossref","unstructured":"Smith MY, Sobel RE, Wallace CA: Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry. Arthritis Care Res (Hoboken). 62: 800-804. 10.1002\/acr.20128.","DOI":"10.1002\/acr.20128"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-8-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1546-0096-8-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-8-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:02:17Z","timestamp":1559422937000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/1546-0096-8-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1186\/1546-0096-8-23","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,16]]},"article-number":"23"}}